Latest News

CHAIN Secures Seed Funding and Appoints New Board Members

London, UK, 23 December, 2015

CHAIN has successfully completed its first round of seed funding last month with the support of a consortium of business angels based in the UK. Business angels are investors who bring expertise and provide start-up capital.  CHAIN will use the funds to strengthen its unique technology platform based on the development of advanced microbes for the production of high value chemicals.

Board Appointments

CHAIN also welcomes Robert Rickman and Paul Green to the Board of Directors. Mr Rickman will act as Chair and Mr Green joins as a non-executive director. Mr Rickman is a Partner in Rockley Group and holds MA and MSc degrees from the University of Oxford. He is a director at Schroder UK Midcap Investment Trust plc and Carclo plc, as well as a number of private companies. Mr Green has over 25 years of professional management experience with leading multinationals in global and Middle East-focused roles.

CHAIN appoints new board members

New board appointees meet with CHAIN founders at Imperial College. From left to right, newly appointed Chairperson, Robert Rickman; CHAIN CEO, Edward Green; Non-Executive Director, Paul Green; and CHAIN CCO, Basil Omar.

Dr Edward Green, Chief Executive of CHAIN, comments, “We are delighted to complete our first investment which provides early validation of our business model.  I am also pleased to welcome Paul and Robert to the Board. Both have a wealth of financial and business acumen that will prove invaluable as CHAIN transitions from an early stage business towards a technology and market leader in Industrial Biotechnology.”

About CHAIN

CHAIN operates at two sites; Imperial College, London and the SBRC at the University of Nottingham.

Central to CHAIN’s business proposition is the provision of a New and Advanced Anaerobic Fermentation Technology Platform for a variety of Industrial Biotechnology products and applications. CHAIN are very interested in forming development partnerships with companies interested in novel reductive enzymes, anti-microbials, bio-polymers & fine/speciality chemicals.  To discuss how our CHAIN’s platform may offer advantages for your particular applications contact Business Development manager Ben Bradley. Ben.bradley@chainbiotech.com

 

Media contact:

Dr David Kirk

david.kirk@chainbiotech.com
+447469819417

Related News

CHAIN Awarded £0.5M Grant Funding to Develop Healthcare Platform

CHAIN Biotech has been awarded £0.5M grant funding from Innovate UK, the UK’s innovation...

CHAIN Appoints New Board Members

CHAIN welcomes to its Board of Directors the recent appointment of Dr Mike McDonald...

CHAIN Finalists in Biotechnology Awards

CHAIN Biotechnology is proud to announce that it is a finalist in two competitions...

CHAIN Celebrates Successful ‘Chiral Chemical Synthesis in Clostridia’ Study

LONDON, UK, 10 AUGUST 2016 -- CHAIN Biotechnology Ltd has successfully completed a 12-month...

omega 3 nutritional supplements
CHAIN Obtains Grant Funding For Collaborative Projects

June 11, 2016 – London, UK. CHAIN Biotechnology Ltd has won grant funding for...

CHAIN new employees clostridium modular vectors omega 3
CHAIN Welcomes New Starters

CHAIN has hired two new world class scientific team members to expand its role...

CHAIN HPLC Analysis of Chiral Chemicals Innovate UK feasibility study for Collaboration Nation: synthetic biology and strain development of anaerobic bacteria
CHAIN Celebrates Feasibility Study Success at Collaboration Nation

CHAIN Biotech has successfully completed a feasibility study into altering bacterial metabolism to produce...

CHAIN Wins Business Interaction Voucher for clostridia strain development
CHAIN Wins Business Interaction Voucher with University of Nottingham

CHAIN Biotechnology has been awarded a £5,000 Business Interaction Voucher in partnership with the...

CHAIN launches a new grant funded research project

CHAIN has been awarded £180K from InnovateUK for a project focused on the production...

CHAIN wins award and launches new website

Award winning CHAIN Biotech launches its new website, funded by a prize voucher from...

CHAIN joins University of Nottingham Synthetic Biology Research Centre

CHAIN Biotechnology Ltd is proud to announce a new collaboration with Professor Nigel Minton’s...

CHAIN hires Research Manager

CHAIN Biotechnology Ltd welcomes Dr Dana Heldt. Dana is an experienced strain development scientist...